Vitamin E as a potential interventional treatment for metabolic syndrome: Evidence from animal and human studies

Frontiers in Pharmacology

Volumn 8, Issue JUL, 2017, Pages

  Wong, Sok Kuan ^a   Chin, Kok Yong ^a   Suhaimi, Farihah Hj ^a   Ahmad, Fairus ^a   Ima Nirwana, Soelaiman ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Dyslipidemia; Hyperglycemia; Hypertension; Metabolic syndrome; Obesity; Tocopherol; Tocotrienol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; TOCOPHEROL;

ANTIDIABETIC ACTIVITY; ANTIHYPERCHOLESTEROLEMIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIOBESITY ACTIVITY; ANTIOXIDANT ACTIVITY; DIABETES MELLITUS; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HOLISTIC CARE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; NONHUMAN; NUTRITIONAL REQUIREMENT; OBESITY; REVIEW; TREATMENT RESPONSE;

EID: 85025476165     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00444     Document Type: Review

References (84)

1. Aasheim, E. T., Hofso, D., Hjelmesaeth, J., Birkeland, K. I., and Bohmer, T. (2008). Vitamin status in morbidly obese patients: a cross-sectional study. Am. J. Clin. Nutr. 87, 362-369.
2. Aggarwal, B. B., Sundaram, C., Prasad, S., and Kannappan, R. (2010). Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem. Pharmacol. 80, 1613-1631. doi: 10.1016/j.bcp.2010.07.043
3. Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645. doi: 10.1161/CIRCULATIONAHA.109.192644
4. Alcala, M., Sanchez-Vera, I., Sevillano, J., Herrero, L., Serra, D., Ramos, M. P., et al. (2015). Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity (Silver. Spring). 23, 1598-1606. doi: 10.1002/oby.21135
5. Allen, P. S., Brown, A. W., Brown, M. M., Hsu, W. H., and Beitz, D. C. (2015). Taurine and vitamin E supplementations have minimal effects on body composition, hepatic lipids, and blood hormone and metabolite concentrations in healthy Sprague Dawley rats. Nutr. Diet. Suppl. 7, 77-85. doi: 10.2147/NDS.S88888
6. Asai, A., Nakagawa, K., and Miyazawa, T. (1999). Antioxidative effects of turmeric, rosemary and capsicum extracts on membrane phospholipid peroxidation and liver lipid metabolism in mice. Biosci. Biotechnol. Biochem. 63, 2118-2122. doi: 10.1271/bbb.63.2118
7. Baburao Jain, A., and Anand Jain, V. (2012). Vitamin E, its beneficial role in diabetes mellitus (DM) and its complications. J. Clin. Diagn. Res. 6, 1624-1628. doi: 10.7860/jcdr/2012/4791.2625
8. Baliarsingh, S., Beg, Z. H., and Ahmad, J. (2005). The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 182, 367-374. doi: 10.1016/j.atherosclerosis.2005.02.020
9. Baradaran, A., Nasri, H., and Rafieian-Kopaei, M. (2014). Oxidative stress and hypertension: possibility of hypertension therapy with antioxidants. J. Res. Med. Sci. 19, 358-367.
10. Boudreau, D. M., Malone, D. C., Raebel, M. A., Fishman, P. A., Nichols, G. A., Feldstein, A. C., et al. (2009). Health care utilization and costs by metabolic syndrome risk factors. Metab. Syndr. Relat. Disord. 7, 305-314. doi: 10.1089/met.2008.0070
11. Brigelius-Flohe, R., and Traber, M. G. (1999). Vitamin E: function and metabolism. FASEB J. 13, 1145-1155.
12. Budin, S. B., Othman, F., Louis, S. R., Bakar, M. A., Das, S., and Mohamed, J. (2009). The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics (Sao. Paulo). 64, 235-244. doi: 10.1590/S1807-59322009000300015
13. Burdeos, G. C., Nakagawa, K., Kimura, F., and Miyazawa, T. (2012). Tocotrienol attenuates triglyceride accumulation in HepG2 cells and F344 rats. Lipids 47, 471-481. doi: 10.1007/s11745-012-3659-0
14. Chin, S. F., Ibahim, J., Makpol, S., Abdul Hamid, N. A., Abdul Latiff, A., Zakaria, Z., et al. (2011). Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: a randomized controlled study. Nutr. Metab. (Lond). 8:42. doi: 10.1186/1743-7075-8-42
15. Chou, T. W., Ma, C. Y., Cheng, H. H., Chen, Y. Y., and Lai, M. H. (2009). A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J. Clin. Biochem. Nutr. 45, 29-36. doi: 10.3164/jcbn.08-257
16. Cornier, M. A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., et al. (2008). The metabolic syndrome. Endocr. Rev. 29, 777-822. doi: 10.1210/er.2008-0024
17. Daud, Z. A., Tubie, B., Sheyman, M., Osia, R., Adams, J., Tubie, S., et al. (2013). Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc. Health Risk Manag. 9, 747-761. doi: 10.2147/VHRM.S51710
18. Devaraj, S., Leonard, S., Traber, M. G., and Jialal, I. (2008). Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic. Biol. Med. 44, 1203-1208. doi: 10.1016/j.freeradbiomed.2007.12.018
19. Engin, K. N. (2009). Alpha-tocopherol: looking beyond an antioxidant. Mol. Vis. 15, 855-860.
20. Evans, H. M., and Bishop, K. S. (1922). On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 56, 650-651. doi: 10.1126/science.56.1458.650
21. Fang, F., Kang, Z., and Wong, C. (2010). Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol. Nutr. Food Res. 54, 345-352. doi: 10.1002/mnfr.200900119
22. Food and Nutrition Board, Institute of Medicine (2000). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids: A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Washington: National Academies Press.
23. Gonzalez, Y., Herrera, M. T., Soldevila, G., Garcia-Garcia, L., Fabian, G., Perez-Armendariz, E. M., et al. (2012). High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes. BMC Immunol. 13:19. doi: 10.1186/1471-2172-13-19
24. Haghighat, N., Vafa, M., Eghtesadi, S., Heidari, I., Hosseini, A., and Rostami, A. (2014). The Effects of tocotrienols added to canola oil on microalbuminuria, inflammation, and nitrosative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Int. J. Prev. Med. 5, 617-623.
25. Han, T. S., and Lean, M. E. (2016). A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM. Cardiovasc. Dis. 5:2048004016633371. doi: 10.1177/2048004016633371
26. Hasty, A. H., Gruen, M. L., Terry, E. S., Surmi, B. K., Atkinson, R. D., Gao, L., et al. (2007). Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model. J. Nutr. Biochem. 18, 127-133. doi: 10.1016/j.jnutbio.2006.03.012
27. Heng, K., Hejar, A., Stanslas, J., Ooi, C., and Loh, S. (2015). Potential of mixed tocotrienol supplementation to reduce cholesterol and cytokines level in adults with metabolic syndrome. Malays. J. Nutr. 21, 231-243.
28. Hosomi, A., Arita, M., Sato, Y., Kiyose, C., Ueda, T., Igarashi, O., et al. (1997). Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS. Lett. 409, 105-108. doi: 10.1016/S0014-5793(97)00499-7
29. Iqbal, J., Minhajuddin, M., and Beg, Z. H. (2003). Suppression of 7,12-dimethylbenz[alpha]anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur. J. Cancer Prev. 12, 447-453. doi: 10.1097/00008469-200312000-00002
30. Irandoost, P., Ebrahimi-Mameghani, M., and Pirouzpanah, S. (2013). Does grape seed oil improve inflammation and insulin resistance in overweight or obese women? Int. J. Food Sci. Nutr. 64, 706-710. doi: 10.3109/09637486.2013.775228
31. Johnson, P., Turner, L., Carter, M., Kelly, R., and Ewell, P. J. (2015). Metabolic syndrome prevalence and correlates in a worksite wellness program. Workplace Health Saf. 63, 245-252. doi: 10.1177/2165079915576920
32. Kamal-Eldin, A., and Appelqvist, L. A. (1996). The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31, 671-701. doi: 10.1007/BF02522884
33. Karmali, S., Johnson Stoklossa, C., Sharma, A., Stadnyk, J., Christiansen, S., Cottreau, D., et al. (2010). Bariatric surgery: a primer. Can. Fam. Physician 56, 873-879.
34. Kataja-Tuomola, M. K., Kontto, J. P., Mannisto, S., Albanes, D., and Virtamo, J. (2011). Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur. J. Clin. Nutr. 65, 590-597. doi: 10.1038/ejcn.2010.283
35. Kaur, J. (2014). A comprehensive review on metabolic syndrome. Cardiol. Res. Pract. 2014:943162. doi: 10.1155/2014/943162
36. Khor, H. T., and Ng, T. T. (2000). Effects of administration of α-tocopherol and tocotrienols on serum lipids and liver HMG CoA reductase activity. Int. J. Food Sci. Nutr. 51, S3-S11. doi: 10.1080/096374800750049521
37. Kuhad, A., Bishnoi, M., Tiwari, V., and Chopra, K. (2009). Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol. Biochem. Behav. 92, 251-259. doi: 10.1016/j.pbb.2008.12.012
38. Kuhad, A., and Chopra, K. (2009a). Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci. 84, 296-301. doi: 10.1016/j.lfs.2008.12.014
39. Kuhad, A., and Chopra, K. (2009b). Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology 57, 456-462. doi: 10.1016/j.neuropharm.2009.06.013
40. Levine, S. (2008). "The 21st century vitamin E? Delta-tocotrienol proves surprisingly potent in fighting cholesterol, cardiovascular disease and cancer," in Focus Nutricology Newsletter, eds J. Neimark, J. L. Anderson, D. Milosevich, D. Raile, and L. Voloshko (California: NutriCology), 2-7.
41. Mah, E., Sapper, T. N., Chitchumroonchokchai, C., Failla, M. L., Schill, K. E., Clinton, S. K., et al. (2015). a-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial. Am. J. Clin. Nutr. 102, 1070-1080. doi: 10.3945/ajcn.115.118570
42. Mahdy, Z. A., Siraj, H. H., Khaza'ai, H., Mutalib, M. S., Azwar, M. H., Wahab, M. A., et al. (2013). Does palm oil vitamin E reduce the risk of pregnancy induced hypertension? Acta Medica (Hradec. Kralove). 56, 104-109. doi: 10.14712/18059694.2014.17
43. Matough, F. A., Budin, S. B., Hamid, Z. A., Abdul-Rahman, M., Al-Wahaibi, N., and Mohammed, J. (2014). Tocotrienol-rich fraction from palm oil prevents oxidative damage in diabetic rats. Sultan Qaboos Univ. Med. J. 14, e95-e103. doi: 10.12816/0003342
44. Minhajuddin, M., Beg, Z. H., and Iqbal, J. (2005). Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem. Toxicol. 43, 747-753. doi: 10.1016/j.fct.2005.01.015
45. Miyamoto, K., Shiozaki, M., Shibata, M., Koike, M., Uchiyama, Y., and Gotow, T. (2009). Very-high-dose alpha-tocopherol supplementation increases blood pressure and causes possible adverse central nervous system effects in stroke-prone spontaneously hypertensive rats. J. Neurosci. Res. 87, 556-566. doi: 10.1002/jnr.21851
46. Montezano, A. C., and Touyz, R. M. (2012). Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann. Med. 44(Suppl. 1), S2-S16. doi: 10.3109/07853890.2011.653393
47. Montonen, J., Knekt, P., Jarvinen, R., and Reunanen, A. (2004). Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27, 362-366. doi: 10.2337/diacare.27.2.362
48. Mustad, V. A., Smith, C. A., Ruey, P. P., Edens, N. K., and DeMichele, S. J. (2002). Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am. J. Clin. Nutr. 76, 1237-1243.
49. Newaz, M. A., Yousefipour, Z., Nawal, N., and Adeeb, N. (2003). Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gamma-tocotrienol. J. Physiol. Pharmacol. 54, 319-327.
50. O'Byrne, D., Grundy, S., Packer, L., Devaraj, S., Baldenius, K., Hoppe, P. P., et al. (2000). Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic. Biol. Med. 29, 834-845. doi: 10.1016/S0891-5849(00)00371-3
51. O'Neill, S., and O'Driscoll, L. (2015). Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 16, 1-12. doi: 10.1111/obr.12229
52. Pazdro, R., and Burgess, J. R. (2010). The role of vitamin E and oxidative stress in diabetes complications. Mech. Ageing Dev. 131, 276-286. doi: 10.1016/j.mad.2010.03.005
53. Qureshi, A. A., Burger, W. C., Peterson, D. M., and Elson, C. E. (1986). The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J. Biol. Chem. 261, 10544-10550.
54. Qureshi, A. A., Khan, D. A., Saleem, S., Silswal, N., Trias, A. M., Tan, B., et al. (2015). Pharmacokinetics and Bioavailability of Annatto I'-tocotrienol in Healthy Fed Subjects. J. Clin. Exp. Cardiolog. 6:411. doi: 10.4172/2155-9880.1000411
55. Qureshi, A. A., and Peterson, D. M. (2001). The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens. Atherosclerosis 156, 39-47. doi: 10.1016/S0021-9150(00)00612-2
56. Qureshi, A. A., Peterson, D. M., Hasler-Rapacz, J. O., and Rapacz, J. (2001a). Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J. Nutr. 131, 223-230.
57. Qureshi, A. A., Reis, J. C., Qureshi, N., Papasian, C. J., Morrison, D. C., and Schaefer, D. M. (2011). delta-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids Health Dis. 10:39. doi: 10.1186/1476-511X-10-39
58. Qureshi, A. A., Sami, S. A., Salser, W. A., and Khan, F. A. (2001b). Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J. Nutr. Biochem. 12, 318-329. doi: 10.1016/S0955-2863(01)00144-9
59. Qureshi, A. A., Sami, S. A., Salser, W. A., and Khan, F. A. (2002). Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161, 199-207. doi: 10.1016/S0021-9150(01)00619-0
60. Raederstorff, D., Elste, V., Aebischer, C., and Weber, P. (2002). Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters. Ann. Nutr. Metab. 46, 17-23. doi: 10.1159/000046748
61. Rasool, A. H., Yuen, K. H., Yusoff, K., Wong, A. R., and Rahman, A. R. (2006). Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J. Nutr. Sci. Vitaminol. 52, 473-478. doi: 10.3177/jnsv.52.473
62. Rodrigo, R., Gonzalez, J., and Paoletto, F. (2011). The role of oxidative stress in the pathophysiology of hypertension. Hypertens. Res. 34, 431-440. doi: 10.1038/hr.2010.264
63. Salman Khan, M., Akhtar, S., Al-Sagair, O. A., and Arif, J. M. (2011). Protective effect of dietary tocotrienols against infection and inflammation-induced hyperlipidemia: an in vivo and in silico study. Phytother. Res. 25, 1586-1595. doi: 10.1002/ptr.3448
64. Sen, C. K., Khanna, S., and Roy, S. (2006). Tocotrienols: vitamin E beyond tocopherols. Life Sci. 78, 2088-2098. doi: 10.1016/j.lfs.2005.12.001
65. Serbinova, E. A., and Packer, L. (1994). Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Meth. Enzymol. 234, 354-366. doi: 10.1016/0076-6879(94)34105-2
66. Serbinova, E., Kagan, V., Han, D., and Packer, L. (1991). Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 10, 263-275. doi: 10.1016/0891-5849(91)90033-Y
67. Shibata, A., Kawakami, Y., Kimura, T., Miyazawa, T., and Nakagawa, K. (2016). alpha-Tocopherol Attenuates the Triglyceride-and Cholesterol-Lowering Effects of Rice Bran Tocotrienol in Rats Fed a Western Diet. J. Agric. Food Chem. 64, 5361-5366. doi: 10.1021/acs.jafc.6b02228
68. Shibata, A., Nakagawa, K., Sookwong, P., Tsuduki, T., Asai, A., and Miyazawa, T. (2010). α-Tocopherol attenuates the cytotoxic effect of d-tocotrienol in human colorectal adenocarcinoma cells. Biochem. Biophys. Res. Commun. 397, 214-219. doi: 10.1016/j.bbrc.2010.05.087
69. Siddiqui, S., Ahsan, H., Khan, M. R., and Siddiqui, W. A. (2013). Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-beta expression. Toxicol. Appl. Pharmacol. 273, 314-324. doi: 10.1016/j.taap.2013.09.004
70. Siddiqui, S., Rashid Khan, M., and Siddiqui, W. A. (2010). Comparative hypoglycemic and nephroprotective effects of tocotrienol rich fraction (TRF) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats. Chem. Biol. Interact. 188, 651-658. doi: 10.1016/j.cbi.2010.08.010
71. Sundram, K., Khor, H. T., Ong, A. S., and Pathmanathan, R. (1989). Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz(a)anthracene. Cancer Res. 49, 1447-1451.
72. Traber, M. G. (2014). Vitamin E inadequacy in humans: causes and consequences. Adv. Nutr. 5, 503-514. doi: 10.3945/an.114.006254
73. Uchida, T., Abe, C., Nomura, S., Ichikawa, T., and Ikeda, S. (2012). Tissue distribution of alpha-and gamma-tocotrienol and gamma-tocopherol in rats and interference with their accumulation by alpha-tocopherol. Lipids 47, 129-139. doi: 10.1007/s11745-011-3620-7
74. Vafa, M., Haghighat, N., Moslehi, N., Eghtesadi, S., and Heydari, I. (2015). Effect of Tocotrienols enriched canola oil on glycemic control and oxidative status in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled clinical trial. J. Res. Med. Sci. 20, 540-547. doi: 10.4103/1735-1995.165945
75. Ward, N. C., Wu, J. H., Clarke, M. W., Puddey, I. B., Burke, V., Croft, K. D., et al. (2007). The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J. Hypertens. 25, 227-234. doi: 10.1097/01.hjh.0000254373.96111.43
76. Weng-Yew, W., and Brown, L. (2011). Nutrapharmacology of tocotrienols for metabolic syndrome. Curr. Pharm. Des. 17, 2206-2214. doi: 10.2174/138161211796957445
77. Wong, S. K., Chin, K. Y., Suhaimi, F. H., Ahmad, F., and Ima-Nirwana, S. (2016b). The relationship between metabolic syndrome and osteoporosis: a review. Nutrients 8:E347. doi: 10.3390/nu8060347
78. Wong, S. K., Chin, K.-Y., Suhaimi, F. H., Fairus, A., and Ima-Nirwana, S. (2016a). Animal models of metabolic syndrome: a review. Nutr. Metab. 13, 65. doi: 10.1186/s12986-016-0123-9
79. Wong, W. Y., Poudyal, H., Ward, L. C., and Brown, L. (2012). Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. Nutrients 4, 1527-1541. doi: 10.3390/nu4101527
80. Wong, W. Y., Ward, L. C., Fong, C. W., Yap, W. N., and Brown, L. (2015). Anti-inflammatory γ-and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats. Eur. J. Nutr. 56, 133-150. doi: 10.1007/s00394-015-1064-1
81. Wu, J. H., Ward, N. C., Indrawan, A. P., Almeida, C. A., Hodgson, J. M., Proudfoot, J. M., et al. (2007). Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin. Chem. 53, 511-519. doi: 10.1373/clinchem.2006.076992
82. Yu, S. G., Thomas, A. M., Gapor, A., Tan, B., Qureshi, N., and Qureshi, A. A. (2006). Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. Lipids 41, 453-461. doi: 10.1007/s11745-006-5119-1
83. Zaiden, N., Yap, W. N., Ong, S., Xu, C. H., Teo, V. H., Chang, C. P., et al. (2010). Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion. J. Atheroscler. Thromb. 17, 1019-1032. doi: 10.5551/jat.4911
84. Zhao, L., Kang, I., Fang, X., Wang, W., Lee, M. A., Hollins, R. R., et al. (2015). Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment. Int. J. Obes. 39, 438-446. doi: 10.1038/ijo.2014.124